Paned: Medgend

Search instead for panel

Paned FDA Approved Drugs

ENALAPRIL MALEATE [Enalapril Maleate^{C₂₀H₂₈N₂O₅C₄H₄O₄}]

10mg (oral tablet)

2.5mg (oral tablet)

20mg (oral tablet)

Apotex^{Mar 23, 2001}
Mylan^{Aug 22, 2000}
Sandoz Inc^{Aug 22, 2000}
Taro^{Jan 23, 2001}
Teva^{Aug 22, 2000}
Wockhardt Usa^{Aug 22, 2000}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

EPANED [Enalapril Maleate^{C₂₀H₂₈N₂O₅C₄H₄O₄}]

1mg/ml (oral solution)

Silvergate Pharms^{Sep 20, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

EPANED KIT [Enalapril Maleate^{C₂₀H₂₈N₂O₅C₄H₄O₄}]

1mg/ml (oral for solution)

Silvergate Pharms^{Aug 13, 2013}

Method of treating hypertension.
Method of treating left ventricular dysfunction.
Method of treatment of heart failure.
Treatment of heart failure.
Treatment of hypertension.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

FARXIGA [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O}]

eq 10mg base (oral tablet)

eq 5mg base (oral tablet)

Astrazeneca Ab^{Jan 8, 2014}

Treatment of type 2 diabetes mellitus in a patient, wherein glycemic control (hba1c < 7.0%) is not achievable using one or more of insulin, metformin, pioglitazone, or rosiglitazone.
Treatment of type 2 diabetes mellitus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

QTERN [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O} : Saxagliptin Hydrochloride^{C₁₈H₂₅N₃O₂ClH}]

eq 10mg base : eq 5mg base (oral tablet)

Astrazeneca Ab^{Feb 27, 2017}

Method for treating type 2 diabetes mellitus (t2dm) in patients who are already treated with dapagliflozin and saxagliptin.
Method for treating type 2 diabetes mellitus (t2dm) in patients who have inadequate control with dapagliflozin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

VASOTEC [Enalapril Maleate^{C₂₀H₂₈N₂O₅C₄H₄O₄}]

10mg (oral tablet)

2.5mg (oral tablet)

20mg (oral tablet)

Valeant Pharms North^{Dec 24, 1985}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

XIGDUO XR [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

eq 10mg base : 1gm (oral tablet, extended release)

eq 10mg base : 500mg (oral tablet, extended release)

eq 5mg base : 1gm (oral tablet, extended release)

eq 5mg base : 500mg (oral tablet, extended release)

Astrazeneca Ab^{Oct 29, 2014}

Treatment of type 2 diabetes mellitus in a patient, wherein glycemic control (hba1c < 7.0%) is not achievable using one or more of insulin, metformin, pioglitazone, or rosiglitazone.
Treatment of type 2 diabetes mellitus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Paned FDA Approved Drugs